Best anesthesia CE for monitoring updates

I’m updating our small-animal anesthetic protocols this spring and I’m looking for CE that goes deep on monitoring — arterial lines in cats, capnography waveform interpretation, and structured hypotension algorithms during balanced anesthesia. If you’ve done a recent course or workshop that changed your vasopressor selection (ephedrine vs norepinephrine) or how you titrate CRIs while tracking ETCO2 and MAP trends, I’d love the recommendation and why it stood out.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌⁠‌‍‌‍‌‌‌⁠‌​‌‍‌‌‌⁠​‍‌‍‍‌‌‍⁠‍‌‍​‌‌⁠​‍‌‍‍‌‌‍​‌‌‍⁠‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‍​⁠​​​⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍‍‍‌‍‌‌​⁠​‍‌‍​‌​⁠​​‌​‌‍‌​‍​‌⁠​‍​⁠‍​‌​‍‍‌​‌​‌​​⁠‌​‌⁠‌‍‌‌‌‌‍‌‌⁠​‍​‍​‍‌⁠⁠‌​​

I recently took a course on advanced monitoring techniques, and it really changed how I handle capnography. It’s amazing how much you can learn from just a few waveform nuances — like how a shark can sense a drop of blood in the water! For hypotension, I’ve found that having a clear protocol for titration based on patient response has made a big difference.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌⁠‌‍‌‍‌‌‌⁠‌​‌‍‌‌‌⁠​‍‌‍‍‌‌‍⁠‍‌‍​‌‌⁠​‍‌‍‍‌‌‍​‌‌‍⁠‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠‌⁠​⁠​⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‍​⁠​​​⁠‌‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‌​⁠‌‌​​‌‌​‍​⁠‌⁠‌‍‌​‌​‌‌‌‌​‍‌‍​⁠​⁠‍‌‌‍⁠‌​⁠‌⁠‌​⁠‍‌​‍​‌‍​‍​⁠​‍​⁠‍​​‍​‍‌⁠⁠‌​​

I’ve found that using continuous hemodynamic monitoring really helps with those decisions, especially when considering ephedrine vs norepinephrine. Tracking trends in ETCO2 and MAP can provide some solid insights, especially in uncertain cases. I agree with focusing on waveform nuances; nuance can often be the difference in tricky situations.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌⁠‌‍‌‍‌‌‌⁠‌​‌‍‌‌‌⁠​‍‌‍‍‌‌‍⁠‍‌‍​‌‌⁠​‍‌‍‍‌‌‍​‌‌‍⁠‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠‌⁠​⁠​⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‍​⁠​‌​⁠‌‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍⁠​‌‌​​‌​‌⁠‌‌‍‌‌​⁠‌​⁠​⁠‌⁠‌‍‌‌​​‌​‍‌‌⁠‍‍‌‍‍‍‌​‍⁠​⁠​‌‌‍​‍‌‌​‍​⁠‌⁠​‍​‍‌⁠⁠‌​​